OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 109 filers reported holding OCULAR THERAPEUTIX INC in Q3 2020. The put-call ratio across all filers is 1.19 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $102,395 | -33.9% | 32,610 | +8.7% | 0.00% | – |
| Q2 2023 | $154,826 | -17.1% | 30,005 | -15.3% | 0.00% | – |
| Q1 2023 | $186,663 | +119.6% | 35,420 | +16.5% | 0.00% | – |
| Q4 2022 | $85,000 | -50.6% | 30,400 | -26.7% | 0.00% | – |
| Q3 2022 | $172,000 | +4.9% | 41,458 | +1.5% | 0.00% | – |
| Q2 2022 | $164,000 | +76.3% | 40,858 | +116.5% | 0.00% | – |
| Q1 2022 | $93,000 | -40.0% | 18,868 | -15.1% | 0.00% | – |
| Q4 2021 | $155,000 | -4.3% | 22,218 | +94.7% | 0.00% | – |
| Q2 2021 | $162,000 | -12.9% | 11,413 | +1.1% | 0.00% | – |
| Q1 2021 | $186,000 | -29.5% | 11,290 | -11.4% | 0.00% | – |
| Q4 2020 | $264,000 | +137.8% | 12,740 | -12.6% | 0.00% | – |
| Q3 2020 | $111,000 | -5.1% | 14,570 | +3.6% | 0.00% | – |
| Q2 2020 | $117,000 | +20.6% | 14,070 | -28.2% | 0.00% | – |
| Q1 2020 | $97,000 | +125.6% | 19,588 | +78.0% | 0.00% | – |
| Q4 2019 | $43,000 | +30.3% | 11,005 | +0.0% | 0.00% | – |
| Q3 2019 | $33,000 | – | 11,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $31,590 | 100.00% |
| Opaleye Management Inc. | 5,780,000 | $29,824,800 | 7.13% |
| DELTEC ASSET MANAGEMENT LLC | 1,974,797 | $10,189,953 | 2.23% |
| Lynwood Capital Management Inc. | 262,500 | $1,354,500 | 1.72% |
| Endurant Capital Management LP | 368,438 | $1,901,140 | 1.66% |
| Knoll Capital Management, LLC | 200,000 | $1,032,000 | 1.25% |
| Knoll Capital Management, LLC | 95,800 | $814,300 | 0.99% |
| SECTORAL ASSET MANAGEMENT INC | 802,680 | $4,141,829 | 0.69% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 300,977 | $1,553,041 | 0.22% |
| Cormorant Asset Management, LP | 645,000 | $3,328,200 | 0.19% |